Levodropropizina Epifarma

Levodropropizine, the active ingredient in Levodropropizina Epifarma, is an antitussive presented as an oral formulation for systemic use. It suppresses cough by acting on peripheral sensory pathways and is indicated for the symptomatic relief of cough in adults and children.

GNH USA supplies Levodropropizina Epifarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodropropizine is used as a peripheral antitussive to manage cough associated with respiratory irritation.

- Acute cough: reduces the frequency and intensity of sudden cough episodes. - Chronic cough: provides ongoing symptom relief for persistent non‑productive cough. - Cough due to upper respiratory tract infection: alleviates irritation‑driven cough during viral or bacterial infections.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Abdominal discomfort: transient pain or cramps. - Taste alteration: temporary change in taste perception. - Headache: mild to moderate intensity. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Allergic reactions: rash, urticaria, or angioedema. - Hepatic enzyme elevation: signs of liver irritation. - Hematologic changes: rare neutropenia or thrombocytopenia. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing or dispensing levodropropizine, consider the following safety measures.

- Pregnancy: safety not established; use only if benefit outweighs potential risk. - Breastfeeding: unknown safety; evaluate risk before use. - Renal impairment: dose adjustment may be required; monitor renal function. - Elderly patients: increased susceptibility to side effects; start with the lowest effective dose. - Drug interactions: review concomitant medications for potential additive effects. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Levodropropizine may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Other central antitussives: risk of excessive cough suppression. - Strong CYP450 inhibitors: may increase levodropropizine plasma concentrations. - Opioids: potential additive respiratory depression.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedation. - Bronchodilators: monitor for altered efficacy. - Alcohol: may increase dizziness or gastrointestinal upset.